Tien Tuan Pharmaceutical Machinery Co. Ltd Listed by crypto24 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Tien Tuan Pharmaceutical Machinery Co. Ltd, a Vietnam-based provider of software and digital solutions for pharmaceutical manufacturing, was listed on 5 June 2025 by the ransomware group known as crypto24. Public reporting states that internal files were exfiltrated in a ransomware attack; the number of people affected remains unknown and further technical details have not been disclosed.

Because the company supplies systems used by major pharmaceutical and biotechnology firms, any compromise of its internal data raises practical questions about the security of manufacturing processes, client relationships and the personal or commercial information such organisations routinely handle. The listing itself is a claim by the threat actor and has not been independently confirmed in the available record.

What happened

On 5 June 2025 the ransomware group crypto24 publicly listed Tien Tuan Pharmaceutical Machinery Co. Ltd as a victim. The only concrete detail supplied in the reporting is that internal files were allegedly exfiltrated during a ransomware attack. No information has been released about the date the intrusion began, the initial access method, the volume of data taken, the specific systems affected, or whether encryption of production systems also occurred. The number of individuals whose data may have been involved is recorded as unknown. Beyond the group’s leak-site claim, independent verification of the incident’s scope remains limited.

Who is crypto24?

Crypto24 is a ransomware operation that follows the now-common double-extortion model: after gaining access to a network, operators exfiltrate data and then encrypt systems, threatening to publish the stolen material if a ransom is not paid. The group maintains a public leak site on which it posts victim names and, in some cases, sample files to increase pressure. Like many contemporary ransomware crews, crypto24 typically targets mid-sized and larger organisations whose operations or reputations make downtime or data exposure costly. Public reporting on the group has documented its use of standard ransomware tooling, data-leak tactics and opportunistic targeting across multiple sectors; no unique claims made by crypto24 specifically about Tien Tuan beyond the listing itself appear in the available facts. The listing should therefore be treated as an unverified assertion by the actor.

About Tien Tuan Pharmaceutical Machinery Co. Ltd

Tien Tuan Pharmaceutical Machinery Co. Ltd is a Vietnam-based company that develops integrated software solutions for the pharmaceutical industry. Its offerings include systems for pharmaceutical lifecycle management, manufacturing execution, and plant intelligence—tools intended to optimise manufacturing and distribution processes. Clients include major global pharmaceutical and biotechnology companies. Organisations of this type typically hold engineering drawings, process parameters, supplier and customer contracts, employee records, and technical documentation that support regulated manufacturing environments. A breach at such a firm can therefore affect not only the company itself but also the wider supply chain that relies on its software and expertise.

What was likely exposed

The available facts state only that “internal files” were exfiltrated. No inventory of file types, volumes or sensitivity levels has been published. Companies that supply pharmaceutical manufacturing software commonly store source code or configuration data, production recipes, quality-control records, client project files, employee personal information, and commercial correspondence. Whether any of these categories were among the files allegedly taken from Tien Tuan remains unconfirmed. Readers should treat any more specific description of the data as speculative until additional verified details emerge.

Why it matters

For individuals whose personal data may have been among the internal files, the principal risks are identity fraud, targeted phishing and unsolicited contact that leverages knowledge of their employment or business relationship with the company. For the organisation, exposure of proprietary process information or client data can damage commercial relationships, trigger regulatory scrutiny under data-protection and pharmaceutical-quality regimes, and create operational disruption if systems remain encrypted or untrusted. Because Tien Tuan’s clients include large pharmaceutical manufacturers, secondary effects could extend to those firms if shared credentials, project files or supply-chain data were involved. None of these outcomes is confirmed; they represent the ordinary consequences that follow when internal corporate files are claimed to have been stolen.

What to do if you're exposed

If you have a past or present relationship with Tien Tuan Pharmaceutical Machinery Co. Ltd—as an employee, contractor, client or supplier—monitor financial and email accounts for unusual activity and treat unexpected messages that reference the company with caution. Change passwords that may have been reused across work and personal services, and enable multi-factor authentication wherever it is available. Consider placing a fraud alert with credit-reporting agencies if you believe personal identifiers were stored in the company’s systems. You can also run a free exposure scan of your email address to check whether it has already appeared in known breach datasets; such a scan provides an early indication but cannot confirm whether your data was part of this specific incident. Official notifications from the company or relevant authorities, if they are issued, should be followed carefully.

AICompiled with AI assistance from public sources and published under our editorial standards.